MDT
97.73
+2.28%↑
VEEV
296
-1.38%↓
A
141.89
+2.46%↑
HQY
88.52
-1.34%↓
PHR.US
23.12
+1.54%↑
MDT
97.73
+2.28%↑
VEEV
296
-1.38%↓
A
141.89
+2.46%↑
HQY
88.52
-1.34%↓
PHR.US
23.12
+1.54%↑
MDT
97.73
+2.28%↑
VEEV
296
-1.38%↓
A
141.89
+2.46%↑
HQY
88.52
-1.34%↓
PHR.US
23.12
+1.54%↑
MDT
97.73
+2.28%↑
VEEV
296
-1.38%↓
A
141.89
+2.46%↑
HQY
88.52
-1.34%↓
PHR.US
23.12
+1.54%↑
MDT
97.73
+2.28%↑
VEEV
296
-1.38%↓
A
141.89
+2.46%↑
HQY
88.52
-1.34%↓
PHR.US
23.12
+1.54%↑
24h
Current
Min
16.95
Max
18.8
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +58.64% upside |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
19 gru 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 27 USD 58.64%
High 30 USD
Low 24 USD
Based on 4 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Strong Buy
4 ratings
3
Buy
1
Hold
0
Sell
Based on 4 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$